Scientists test new Pill's journey to brain tumors
NCT ID NCT06636162
Summary
This early study is testing whether an experimental oral drug called DSP-0390 can reach brain tumors in sufficient amounts and affect tumor cell metabolism. Researchers will give the drug for about two weeks to 20 patients with specific types of brain tumors (grade II/III gliomas) who are already scheduled for surgical removal. They will measure drug levels and cholesterol-related markers in tumor tissue removed during surgery and in blood samples to understand how the drug behaves.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOMA, MALIGNANT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Washington University School of Medicine
RECRUITINGSt Louis, Missouri, 63110, United States
Contact
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Conditions
Explore the condition pages connected to this study.